Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cidara Thera (CDTX)

Cidara Thera (CDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Wall Street - shutterstock_94127350
Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus Barchart - 1 hour ago

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed...

ESM24 : 5,073.00 (-0.68%)
NQM24 : 17,482.50 (-1.03%)
META : 493.50 (-0.52%)
TSLA : 162.13 (+12.06%)
HAS : 65.03 (+11.85%)
TXN : 174.81 (+5.64%)
ODFL : 195.06 (-11.05%)
MSFT : 409.06 (+0.37%)
GOOGL : 159.13 (+0.55%)
MRK : 127.00 (+0.09%)
GILD : 67.08 (+0.07%)
CAT : 363.52 (+0.07%)
Cidara Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 2, 2023

Cidara Therapeutics: Q3 Earnings Snapshot

CDTX : 12.29 (+19.90%)
Cidara Therapeutics: Q2 Earnings Snapshot AP - Thu Aug 3, 2023

Cidara Therapeutics: Q2 Earnings Snapshot

CDTX : 12.29 (+19.90%)
Cidara Therapeutics: Q1 Earnings Snapshot AP - Thu May 11, 2023

Cidara Therapeutics: Q1 Earnings Snapshot

CDTX : 12.29 (+19.90%)
Merus N.V. (MRUS) Reports Q1 Loss, Tops Revenue Estimates Zacks - Thu May 4, 2023

Merus N.V. (MRUS) delivered earnings and revenue surprises of 19.63% and 27.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MRUS : 41.97 (+2.82%)
CDTX : 12.29 (+19.90%)
Are Options Traders Betting on a Big Move in Cidara (CDTX) Stock? Zacks - Tue Apr 4, 2023

Investors need to pay close attention to Cidara (CDTX) stock based on the movements in the options market lately.

CDTX : 12.29 (+19.90%)
Cidara Therapeutics (CDTX) Reports Q4 Loss, Misses Revenue Estimates Zacks - Thu Mar 23, 2023

Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of -1,800% and 45.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

CDTX : 12.29 (+19.90%)
CRMD : 5.33 (-2.20%)
Cidara Therapeutics: Q4 Earnings Snapshot AP - Thu Mar 23, 2023

Cidara Therapeutics: Q4 Earnings Snapshot

CDTX : 12.29 (+19.90%)
Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis Business Wire - Wed Mar 22, 2023

Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced that the U.S. Food and Drug Administration (FDA) approved REZZAYO™ (rezafungin for injection) for the treatment...

CDTX : 12.29 (+19.90%)
Horizon Therapeutics (HZNP) Q4 Earnings and Revenues Top Estimates Zacks - Wed Mar 1, 2023

Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of 11.01% and 1.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HZNP : 116.30 (+0.04%)
CDTX : 12.29 (+19.90%)

Barchart Exclusives

Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus Barchart - 1 hour ago
June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed on sentiment, while market participants braced for a new round of U.S. economic data and quarterly reports from heavyweight names. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot